PreveCeutical Medical Inc. (CSE:PREV)
Canada · Delayed Price · Currency is CAD 0.0200
0.00 (0.00%)
Oct 30, 2026, 1:59 PM EDT
PreveCeutical Medical Market Cap
PreveCeutical Medical has a market cap or net worth of CAD 12.76 million as of October 30, 2026. It is the 41,900th most valuable company in the world and the 1,465th biggest in Canada. Its market cap has decreased by 60.45% in one year.
Market Cap
12.76M
Enterprise Value
17.57M
Revenue
n/a
Global Rank
Country Rank
#1,465 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since July 14, 2017, PreveCeutical Medical's market cap has increased from 6.06M to 12.76M, an increase of 110.53%. That is a compound annual growth rate of 8.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 12.76M | -14.65% |
| Dec 31, 2025 | 14.95M | 10.43% |
| Dec 31, 2024 | 13.54M | 1.20% |
| Dec 29, 2023 | 13.38M | - |
| Dec 30, 2022 | 13.38M | 4.61% |
| Dec 29, 2021 | 12.79M | -13.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmala Biotech Holdings | 18.10M |
| Onco-Innovations | 16.61M |
| Rapid Dose Therapeutics | 14.47M |
| Lobe Sciences | 13.58M |
| Alzai Health | 12.96M |
| Hemostemix | 12.69M |
| Britannia Life Sciences | 11.52M |
| Marvel Biosciences | 8.86M |